Synthesis and molecular modeling of six novel monastrol analogues: evaluation of cytotoxicity and kinesin inhibitory activity against HeLa cell line
Open Access
- 19 December 2013
- journal article
- research article
- Published by Springer Nature in DARU Journal of Pharmaceutical Sciences
- Vol. 21 (1) , 70
Abstract
Background and the purpose of the study: A common approach in cancer chemotherapy is development of drugs that interrupt the mitosis phase of cell division. Dimethylenastron is a known kinesin inhibitor. In this study, six novel dimethylenastron analogues (4a-f), in which 3-hydroxyphenyl substituent has been replaced with substituted benzylimidazolyl, were synthesized through Biginelli reaction. Methods: Six novel Biginelli compounds (4a-f) were synthesized through one step Biginelli reaction of imidazole aldehydes (3a-c), dimedone and urea or thioura. In vitro cytotoxicities of prepared compounds were investigated using MTT assay. Furthermore the ELIPA kit was implemented to study inhibitory effects of synthesized compounds on ATPase activity of kinesin by measuring of organic phosphate. Results: Our results indicated that analogue 4c is the most toxic and analogues 4f, 4b and dimethylenasteron were less cytotoxic in compare with other analogues. On the other hand, analogue 4a, 4b, 4c and 4e showed stronger Kinesin inhibition as compared with analogue 4f and dimethylenasteron. None of synthesized compounds were as potent kinesin inhibitor as Taxol. Docking analysis revealed that hydrogen bond formation and hydrophobic interactions were the key factors affecting inhibitory effects of these compounds. Conclusion: Newly synthesized compounds were found to have moderate to good cytotoxicity against HeLa cancer cell. Our results may be helpful in further design of dihydropyrimidine as potential anticancer agents.Keywords
This publication has 20 references indexed in Scilit:
- Synthesis and In vitro cytotoxic activity evaluation of (E)-16-(substituted benzylidene) derivatives of dehydroepiandrosteroneDARU Journal of Pharmaceutical Sciences, 2013
- Synthesis and cytotoxic properties of novel (E)-3-benzylidene-7-methoxychroman-4-one derivativesDARU Journal of Pharmaceutical Sciences, 2013
- Synthesis and Immunomodulation of Human Lymphocyte Proliferation and Cytokine (Interferon‐γ) Production of Four Novel MalonitrilamidesChemical Biology & Drug Design, 2009
- ATPase Mechanism of Eg5 in the Absence of Microtubules: Insight into Microtubule Activation and Allosteric Inhibition by MonastrolBiochemistry, 2005
- Synthesis and biological evaluation of new tetrahydro-β-carbolines as inhibitors of the mitotic kinesin Eg5Bioorganic & Medicinal Chemistry, 2005
- Development and Biological Evaluation of Potent and Specific Inhibitors of Mitotic Kinesin Eg5ChemBioChem, 2005
- Monastrol, a prototype anti‐cancer drug that inhibits a mitotic kinesin, induces rapid bursts of axonal outgrowth from cultured postmitotic neuronsCell Motility, 2004
- Interaction of the Mitotic Inhibitor Monastrol with Human Kinesin Eg5Biochemistry, 2002
- Small-molecule inhibitors of the cell cycleCurrent Opinion in Chemical Biology, 2000
- Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based ScreenScience, 1999